| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2008 | EP1748990B1 Process for the preparation of telmisartan |
| 06/25/2008 | EP1740120A4 Naltrexone long acting formulations and methods of use |
| 06/25/2008 | EP1730140B1 Opioid receptor antagonists |
| 06/25/2008 | EP1730127B1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 06/25/2008 | EP1730119B1 Imidazole compounds for the treatment of neurodegenerative disorders |
| 06/25/2008 | EP1725552B1 New quaternized quinuclidine esters |
| 06/25/2008 | EP1718336B1 Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
| 06/25/2008 | EP1697350B1 Tricyclic steroid hormone nuclear receptor modulators |
| 06/25/2008 | EP1684806B1 Compositions comprising l-type calcium channel blockers and cholinesterase inhibitors |
| 06/25/2008 | EP1678499B1 Chemical compound and assay |
| 06/25/2008 | EP1675854B1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 06/25/2008 | EP1675850B1 Quinoline compounds and their uses |
| 06/25/2008 | EP1670796B1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 06/25/2008 | EP1658050B1 Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs |
| 06/25/2008 | EP1617826B1 The dispersible alendronate microparticle formulation |
| 06/25/2008 | EP1603572A4 Lactam-containing cyclic diamines and derivatives as factor xa inhibitors |
| 06/25/2008 | EP1572181B1 Pharmaceutical composition comprising a beta-3-adrenoceptor agonist and a serotonin and/or norepinephrine reuptake inhibitor and the use of said composition for treating bladder dysfunction |
| 06/25/2008 | EP1560834B1 New tricyclic derivatives as ltd4 antagonists |
| 06/25/2008 | EP1556375B1 Flavone derivatives as inhibitors of cyclin-dependent kinases |
| 06/25/2008 | EP1534313A4 Ophthalmologic irrigation solutions and method |
| 06/25/2008 | EP1492534B1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 06/25/2008 | EP1492499B1 Formoterol and mometasone aerosol formulations |
| 06/25/2008 | EP1458393B1 Substituted diketopiperazines as oxytocin antagonists |
| 06/25/2008 | EP1450771B1 Pharmaceutical preparations useful for treating lesions of the skin and the mucous membranes and methods and kits using same |
| 06/25/2008 | EP1395604B1 Novel anti inflammatory 17.alpha.-heterocyclic-esters of 17.beta.-carbothioate androstane derivatives |
| 06/25/2008 | EP1351683B1 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
| 06/25/2008 | EP1328271B1 Treatment of neurological and neuropsychological disorders |
| 06/25/2008 | EP1322304A4 Manipulation of oxidative phosphorylation for hypersensitizing tumor cells to glycolytic inhibitors |
| 06/25/2008 | EP1286962B1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| 06/25/2008 | EP1278535B1 Uses of tgap7 for the modulation of leucocyte activation |
| 06/25/2008 | EP1261320B1 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 06/25/2008 | EP1200127B1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 06/25/2008 | EP1173180B1 Camptothecin analogs and methods of preparation thereof |
| 06/25/2008 | EP1107789B1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| 06/25/2008 | EP1041991B1 Non antibacterial tetracyclins for the treatment of multiple sclerosis |
| 06/25/2008 | EP1015027B1 Process for preparing conjugate vaccines including free protein |
| 06/25/2008 | EP0986382B1 Raf kinase inhibitors |
| 06/25/2008 | EP0942915B1 Pharmaceutical formulations |
| 06/25/2008 | CN201076616Y Female health care suppository pill |
| 06/25/2008 | CN101208437A Biosensors for detecting macromolecules and other analytes |
| 06/25/2008 | CN101208352A Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
| 06/25/2008 | CN101208345A (S)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208344A (R)-N-methylnaltrexone, processes for its synthesis and its pharmaceutical use |
| 06/25/2008 | CN101208342A Pyrrolobenzodiazepine pyridine carboxamides and derivatives as follicle-stimulating hormone receptor antagonists |
| 06/25/2008 | CN101208340A Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 06/25/2008 | CN101208339A Heterocyclic benzylamino derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | CN101208338A Azabenzimidazole derivatives, their manufacture and use as anti-cancer agents |
| 06/25/2008 | CN101208336A Thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents |
| 06/25/2008 | CN101208335A Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| 06/25/2008 | CN101208334A Novel cyclic amines |
| 06/25/2008 | CN101208333A Solid forms of 1-(5-(1H-1,2,4-triazol-5-yl)(1H-indazol-3-yl))-3-(2-piperidylethoxy)benzene |
| 06/25/2008 | CN101208332A Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase |
| 06/25/2008 | CN101208331A Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors |
| 06/25/2008 | CN101208329A Pyrimidine derivatives and their use in the treatment of cancer |
| 06/25/2008 | CN101208328A Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals |
| 06/25/2008 | CN101208327A New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 06/25/2008 | CN101208326A Derivate von dihydroxyphenylalanin |
| 06/25/2008 | CN101208325A Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents |
| 06/25/2008 | CN101208324A Benzo[b]furane and benzo[b]thiophene derivatives |
| 06/25/2008 | CN101208320A N-hydroxyamide derivatives and use thereof |
| 06/25/2008 | CN101208315A Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors |
| 06/25/2008 | CN101208314A Benzisoxazole piperazine compounds and methods of use thereof |
| 06/25/2008 | CN101208312A Method of synthesis of anastrozole and purification of one of its intermediate |
| 06/25/2008 | CN101208311A Pyrazine -2-carboxamide derivatives as mglur5 antagonists |
| 06/25/2008 | CN101208310A New crystal forms of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide |
| 06/25/2008 | CN101208309A Chloro-substituted guanidines |
| 06/25/2008 | CN101208308A 8-alk0xy-4-methyl-3, 4-dihydr0-quinaz0lin-2-yl amines and their use as 5-ht5a receptor ligands |
| 06/25/2008 | CN101208307A Process for preparing amorphous rosuvastatin calcium free of impurities |
| 06/25/2008 | CN101208306A Pyrazole compounds and antidiabetes agents containing the same |
| 06/25/2008 | CN101208304A Quinoline 3-sulfonate esters as NK3 receptor modulators |
| 06/25/2008 | CN101208303A CGRP receptor antagonists |
| 06/25/2008 | CN101208302A Novel 4-aminopiperidine derivatives as plasmepsin ii inhibitors |
| 06/25/2008 | CN101208301A Bicyclic derivatives as p38 kinase inhibitors |
| 06/25/2008 | CN101208300A Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics |
| 06/25/2008 | CN101208299A Diarylsulfone sulfonamides and use therof |
| 06/25/2008 | CN101208297A Antiviral compounds and methods |
| 06/25/2008 | CN101208294A TRPV1 agonist compounds and methods for making and using the same |
| 06/25/2008 | CN101208107A Quadraphasis continuous graduated estrogen contraceptive |
| 06/25/2008 | CN101208097A Method for the treatment of acne |
| 06/25/2008 | CN101208096A Use of a clobetasol spray formulation to treat psoriasis |
| 06/25/2008 | CN101208095A Use of reboxetine for the treatment of pain |
| 06/25/2008 | CN101208094A Pharmacokinetically improved compounds |
| 06/25/2008 | CN101208093A Use of pyrazolyl-pyrimidine derivatives in the treatment of pain |
| 06/25/2008 | CN101208092A Methods and compositions for managing psychotic disorders |
| 06/25/2008 | CN101208091A Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 06/25/2008 | CN101208090A Stabilized composition |
| 06/25/2008 | CN101208089A 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 Aminothiazole derivatives as human stearoyl desaturase inhibitor -CoA |
| 06/25/2008 | CN101208088A Phenylalkyl substituted heteroaryl devivatives |
| 06/25/2008 | CN101208087A Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 06/25/2008 | CN101208086A Indoloquinone tumor radiation sensitization |
| 06/25/2008 | CN101208085A Mofified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation |
| 06/25/2008 | CN101208084A Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 06/25/2008 | CN101208083A Treatment with statin and Omega-3 fatty acids and a combination product thereof |
| 06/25/2008 | CN101208082A Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 06/25/2008 | CN101208080A Medicament for the treatment of impaired glucose metabolism |
| 06/25/2008 | CN101208079A Methods of suppressing UV light-induced skin carcinogenesis |
| 06/25/2008 | CN101208078A Oral medicament based on a proton pump inhibitors |
| 06/25/2008 | CN101208076A Controlled release formulations exhibiting an ascending rate of release |
| 06/25/2008 | CN101208010A Beta-lactamylalkanoic acids for treating premenstrual disorders |
| 06/25/2008 | CN101205555A Schistosoma japonicum resistant medicine action target, medicine sifting method and lead compounds |